These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24140751)

  • 21. Synthesis of secretory leukocyte protease inhibitor using cell-free protein synthesis system.
    Hiroshima Y; Kido R; Kido JI; Bando M; Yoshida K; Murakami A; Shinohara Y
    Odontology; 2024 Oct; 112(4):1103-1112. PubMed ID: 38502469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.
    Farquhar C; VanCott TC; Mbori-Ngacha DA; Horani L; Bosire RK; Kreiss JK; Richardson BA; John-Stewart GC
    J Infect Dis; 2002 Oct; 186(8):1173-6. PubMed ID: 12355371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.
    Huppert JS; Huang B; Chen C; Dawood HY; Fichorova RN
    J Infect Dis; 2013 May; 207(9):1462-70. PubMed ID: 23355743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
    Skott P; Lucht E; Ehnlund M; Björling E
    Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary secretory leukocyte protease inhibitor levels in patients with stage 3 grade C periodontitis: a comparative cross-sectional study.
    Afacan B; Öztürk VÖ; Emingil G; Köse T; Mitsakakis K; Bostanci N
    Sci Rep; 2022 Dec; 12(1):21267. PubMed ID: 36481656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection.
    Lange A; Cajander S; Magnuson A; Sundén-Cullberg J; Strålin K; Hultgren O
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1425-1434. PubMed ID: 31089838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.
    Yang Y; Rhodus NL; Ondrey FG; Wuertz BR; Chen X; Zhu Y; Griffin TJ
    PLoS One; 2014; 9(4):e95389. PubMed ID: 24748380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis.
    Shimoya K; Moriyama A; Ogata I; Nobunaga T; Koyama M; Azuma C; Murata Y
    Mol Hum Reprod; 2000 Sep; 6(9):829-34. PubMed ID: 10956555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
    J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition.
    Orfanelli T; Jayaram A; Doulaveris G; Forney LJ; Ledger WJ; Witkin SS
    Reprod Sci; 2014 Apr; 21(4):538-42. PubMed ID: 24023032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
    Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
    Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
    Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The change of secretory leukocyte protease inhibitor and its correlation with elastase in the development of periodontal inflammation].
    Zhou M; Meng HX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Oct; 46(10):581-5. PubMed ID: 22321625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of secretory leukocyte protease inhibitor expression in gastric mucosa is a general phenomenon in Helicobacter pylori-related gastroduodenal diseases.
    Wex T; Sokic-Milutinovic A; Todorovic V; Bjelovic M; Milosavljevic T; Pesko P; Malfertheiner P
    Dig Dis; 2004; 22(4):390-5. PubMed ID: 15812165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients.
    Nicol AF; Brunette LL; Nuovo GJ; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Coutinho JR; Vianna-Andrade C; Oliveira NS; Woodham AW; DA Silva DM; Kast WM
    J Acquir Immune Defic Syndr; 2016 Sep; 73(1):27-33. PubMed ID: 27149102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.
    Cooper MD; Roberts MH; Barauskas OL; Jarvis GA
    Am J Reprod Immunol; 2012 Aug; 68(2):116-27. PubMed ID: 22537232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein.
    Shine NR; Wang SC; Konopka K; Burks EA; Düzgüneş N; Whitman CP
    Bioorg Chem; 2002 Aug; 30(4):249-63. PubMed ID: 12392704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia/reperfusion injury in cardiac transplantation.
    Schneeberger S; Hautz T; Wahl SM; Brandacher G; Sucher R; Steinmassl O; Steinmassl P; Wright CD; Obrist P; Werner ER; Mark W; Troppmair J; Margreiter R; Amberger A
    Am J Transplant; 2008 Apr; 8(4):773-82. PubMed ID: 18294346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris.
    Li Z; Moy A; Sohal K; Dam C; Kuo P; Whittaker J; Whittaker M; Düzgünes N; Konopka K; Franz AH; Lin-Cereghino J; Lin-Cereghino GP
    Protein Expr Purif; 2009 Oct; 67(2):175-81. PubMed ID: 19505578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
    McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
    Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.